These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11092220)

  • 1. Recombinant FVIIa in the treatment of warfarin bleeding.
    Berntorp E
    Semin Thromb Hemost; 2000; 26(4):433-5. PubMed ID: 11092220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of thromboembolic events after protocolized warfarin reversal with 3-factor PCC and factor VIIa.
    Barton CA; Johnson NB; Case J; Warden B; Hughes D; Zimmerman J; Roberti G; McMillian WD; Schreiber M
    Am J Emerg Med; 2015 Nov; 33(11):1562-6. PubMed ID: 26143317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
    Brody DL; Aiyagari V; Shackleford AM; Diringer MN
    Neurocrit Care; 2005; 2(3):263-7. PubMed ID: 16159073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
    Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
    World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NovoSeven in warfarin-treated patients.
    Berntorp E; Stigendal L; Lethagen S; Olofsson L; Hedner U
    Blood Coagul Fibrinolysis; 2000 Apr; 11 Suppl 1():S113-5. PubMed ID: 10850575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of elevated international normalized ratios and bleeding with low-dose recombinant activated factor VII in patients receiving warfarin.
    Dager WE; King JH; Regalia RC; Williamson D; Gosselin RC; White RH; Tharratt RS; Albertson TE
    Pharmacotherapy; 2006 Aug; 26(8):1091-8. PubMed ID: 16863486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protocolized warfarin reversal with 4-factor prothrombin complex concentrate versus 3-factor prothrombin complex concentrate with recombinant factor VIIa.
    Barton CA; Hom M; Johnson NB; Case J; Ran R; Schreiber M
    Am J Surg; 2018 May; 215(5):775-779. PubMed ID: 29338845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: clinical and biochemical aspects.
    Sørensen B; Johansen P; Nielsen GL; Sørensen JC; Ingerslev J
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):469-77. PubMed ID: 12851533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate.
    Deveras RA; Kessler CM
    Ann Intern Med; 2002 Dec; 137(11):884-8. PubMed ID: 12458988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warfarin reversal.
    Hanley JP
    J Clin Pathol; 2004 Nov; 57(11):1132-9. PubMed ID: 15509671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of warfarin-associated intracerebral hemorrhage: literature review and expert opinion.
    Aguilar MI; Hart RG; Kase CS; Freeman WD; Hoeben BJ; García RC; Ansell JE; Mayer SA; Norrving B; Rosand J; Steiner T; Wijdicks EF; Yamaguchi T; Yasaka M
    Mayo Clin Proc; 2007 Jan; 82(1):82-92. PubMed ID: 17285789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage.
    Rowe AS; Turner RM
    Am J Health Syst Pharm; 2010 Mar; 67(5):361-5. PubMed ID: 20172985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controversies of anticoagulation reversal in life-threatening bleeds.
    Rolfe S; Papadopoulos S; Cabral KP
    J Pharm Pract; 2010 Jun; 23(3):217-25. PubMed ID: 21507817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Summaries for patients. A new way to reverse excessive blood thinning from warfarin.
    Ann Intern Med; 2002 Dec; 137(11):I41. PubMed ID: 12459002
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid reversal of warfarin-associated hemorrhage in the emergency department by prothrombin complex concentrates.
    Frumkin K
    Ann Emerg Med; 2013 Dec; 62(6):616-626.e8. PubMed ID: 23829955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergent reversal of vitamin K antagonists: addressing all the factors.
    Martin DT; Barton CA; Dodgion C; Schreiber M
    Am J Surg; 2016 May; 211(5):919-25. PubMed ID: 27046797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemorrhagic complications during warfarin treatment].
    Gumulec J; Kessler P; Penka M; Klodová D; Králová S; Brejcha M; Wróbel M; Sumná E; Blatný J; Klaricová K; Riedlová P; Lasota Z
    Vnitr Lek; 2006 Mar; 52 Suppl 1():79-91. PubMed ID: 16637455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Oral Anticoagulant- or Warfarin-Related Major Bleeding: Characteristics, Reversal Strategies, and Outcomes From a Multicenter Observational Study.
    Xu Y; Schulman S; Dowlatshahi D; Holbrook AM; Simpson CS; Shepherd LE; Wells PS; Giulivi A; Gomes T; Mamdani M; Khuu W; Frymire E; Johnson AP;
    Chest; 2017 Jul; 152(1):81-91. PubMed ID: 28219635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiences with an activated 4-factor prothrombin complex concentrate (FEIBA) for reversal of warfarin-related bleeding.
    Stewart WS; Pettit H
    Am J Emerg Med; 2013 Aug; 31(8):1251-4. PubMed ID: 23763937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is recombinant FVIIa the magic bullet in the treatment of major bleeding?
    Spahn DR; Tucci MA; Makris M
    Br J Anaesth; 2005 May; 94(5):553-5. PubMed ID: 15814804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.